Taro Pharmaceutical Industries Ltd (DELISTED) (TARO:DL)
42.97
0.00 (0.00%)
USD |
NYSE |
Jun 25, 16:00
Taro Pharmaceutical Industries Enterprise Value: 735.66M for June 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 25, 2024 | 735.66M |
| June 24, 2024 | 735.66M |
| June 21, 2024 | 735.66M |
| June 20, 2024 | 735.66M |
| June 18, 2024 | 729.65M |
| June 17, 2024 | 729.27M |
| June 14, 2024 | 726.64M |
| June 13, 2024 | 727.01M |
| June 12, 2024 | 726.64M |
| June 11, 2024 | 727.77M |
| June 10, 2024 | 727.77M |
| June 07, 2024 | 728.14M |
| June 06, 2024 | 731.15M |
| June 05, 2024 | 731.52M |
| June 04, 2024 | 725.51M |
| June 03, 2024 | 729.27M |
| May 31, 2024 | 730.02M |
| May 30, 2024 | 724.76M |
| May 29, 2024 | 715.74M |
| May 28, 2024 | 725.14M |
| May 24, 2024 | 725.14M |
| May 23, 2024 | 727.39M |
| May 22, 2024 | 728.52M |
| May 21, 2024 | 718.75M |
| May 20, 2024 | 714.99M |
| Date | Value |
|---|---|
| May 17, 2024 | 710.48M |
| May 16, 2024 | 706.72M |
| May 15, 2024 | 712.36M |
| May 14, 2024 | 711.61M |
| May 13, 2024 | 706.34M |
| May 10, 2024 | 710.48M |
| May 09, 2024 | 714.61M |
| May 08, 2024 | 709.73M |
| May 07, 2024 | 714.99M |
| May 06, 2024 | 717.24M |
| May 03, 2024 | 716.12M |
| May 02, 2024 | 718.37M |
| May 01, 2024 | 713.86M |
| April 30, 2024 | 717.24M |
| April 29, 2024 | 717.24M |
| April 26, 2024 | 714.24M |
| April 25, 2024 | 717.24M |
| April 24, 2024 | 706.72M |
| April 23, 2024 | 707.85M |
| April 22, 2024 | 708.97M |
| April 19, 2024 | 708.60M |
| April 18, 2024 | 706.34M |
| April 17, 2024 | 708.22M |
| April 16, 2024 | 701.08M |
| April 15, 2024 | 703.71M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
24.95M
Minimum
Mar 28 2023
2.722B
Maximum
Dec 06 2019
1.044B
Average
928.66M
Median
Feb 03 2022
Enterprise Value Benchmarks
| InspireMD Inc | 21.22M |
| BiomX Inc | 17.50M |
| Alpha Tau Medical Ltd | 102.11M |
| Pluri Inc | 28.95M |
| Holdco Nuvo Group DG Ltd | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 15.08M |
| Revenue (Quarterly) | 164.94M |
| Total Expenses (Quarterly) | 156.16M |
| EPS Diluted (Quarterly) | 0.40 |
| Gross Profit Margin (Quarterly) | 52.98% |
| Profit Margin (Quarterly) | 9.14% |
| Earnings Yield | 3.35% |
| Operating Earnings Yield | 1.33% |
| Normalized Earnings Yield | 3.345 |